Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice

Journal of Inherited Metabolic Disease

Volumn 36, Issue 6, 2013, Pages 973-981

  Bakermans, Adrianus J ^a   Van Weeghel, Michel ^b   Denis, Simone ^b   Nicolay, Klaas ^a   Prompers, Jeanine J ^a   Houten, Sander M ^b  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; LIPID; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARNITINE SUPPLEMENTATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME DEFICIENCY; EX VIVO STUDY; HEART FUNCTION; HEART MUSCLE; HEART SIZE; HEART VENTRICLE HYPERTROPHY; KNOCKOUT MOUSE; LIPID STORAGE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; LONGITUDINAL STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROTON NUCLEAR MAGNETIC RESONANCE; WILD TYPE;

ACYL-COA DEHYDROGENASE, LONG-CHAIN; ANIMALS; CARNITINE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HEART; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; TRIGLYCERIDES;

EID: 84888203200     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-013-9604-4     Document Type: Article

References (29)

1. Bakermans AJ, Geraedts TR, van Weeghel M et al (2011) Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular function. Circ Cardiovasc Imaging 4(5):558-565
2. Baruteau J, Sachs P, Broue P et al (2012) Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. J Inherit Metab Dis doi:10.1007/s10545- 012-9542-6
3. Bonnet D, Martin D, de Lonlay P et al (1999) Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100(22):2248-2253
4. Calvani M, Reda E, Arrigoni-Martelli E (2000) Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol 95(2):75-83
5. Chegary M, te Brinke H, Ruiter JP et al (2009) Mitochondrial long chain fatty acid beta-oxidation in man and mouse. Biochim Biophys Acta 1791(8):806-815
6. Chess DJ, Stanley WC (2008) Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc Res 79(2):269-278
7. Cox KB, Hamm DA, Millington DS et al (2001) Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. Hum Mol Genet 10(19):2069-2077
8. Cox KB, Liu J, Tian L, Barnes S, Yang Q, Wood PA (2009) Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency. Lab Invest 89(12):1348-1354
9. DaTorre SD, Creer MH, Pogwizd SM, Corr PB (1991) Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 23(Suppl 1):11-22
10. Goldberg IJ, Trent CM, Schulze PC (2012) Lipid metabolism and toxicity in the heart. Cell Metab 15(6):805-812
11. Hale DE, Batshaw ML, Coates PM et al (1985) Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res 19(7):666-671
12. Heijman E, Aben JP, Penners C et al (2008) Evaluation of manual and automatic segmentation of the mouse heart from CINE MR images. J Magn Reson Imaging 27(1):86-93
13. Kurtz DM, Rinaldo P, Rhead WJ et al (1998) Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc Natl Acad Sci U S A 95(26):15592-15597
14. Liebig M, Gyenes M, Brauers G et al (2006) Carnitine supplementation induces long-chain acylcarnitine production - studies in the VLCAD-deficient mouse. J Inherit Metab Dis 29(2-3):343-344
15. Potter BK, Little J, Chakraborty P et al (2012) Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians. J Inherit Metab Dis 35(1):115-123
16. Primassin S, ter Veld F, Mayatepek E, Spiekerkoetter U (2008) Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine. Pediatr Res 63(6):632-637
17. Rinaldo P, Matern D, Bennett MJ (2002) Fatty acid oxidation disorders. Annu Rev Physiol 64:477-502
18. 1H-MRS in the mouse. Magn Reson Med 52(5):1029-1035
19. Spiekerkoetter U, Lindner M, Santer R et al (2009) Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis 32(4):498-505
20. Spiekerkoetter U, Bastin J, Gillingham M, Morris A, Wijburg F, Wilcken B (2010) Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis 33(5):555-561
21. Stanley CA, Hale DE, Coates PM et al (1983) Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res 17(11):877-884
22. Touma EH, Rashed MS, Vianey-Saban C et al (2001) A severe genotype with favourable outcome in very long chain acyl-CoA dehydrogenase deficiency. Arch Dis Child 84(1):58-60
23. Treem WR, Stanley CA, Hale DE, Leopold HB, Hyams JS (1991) Hypoglycemia, hypotonia, and cardiomyopathy: the evolving clinical picture of long-chain acyl-CoA dehydrogenase deficiency. Pediatrics 87(3):328-333
24. van Vlies N, Tian L, Overmars H et al (2005) Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse. Biochem J 387(Pt 1):185-193
25. Vanhamme L, van den Boogaart A, van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129(1):35-43
26. Ventura FV, Ijlst L, Ruiter J et al (1998) Carnitine palmitoyltransferase II specificity towards beta-oxidation intermediates - evidence for a reverse carnitine cycle in mitochondria. Eur J Biochem 253(3):614-618
27. 13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta 281(1-2):1-17
28. Wanders RJ, Vreken P, den Boer ME, Wijburg FA, van Gennip AH, IJlst L (1999) Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis 22(4):442-487
29. Winter SC (2003) Treatment of carnitine deficiency. J Inherit Metab Dis 26(2-3):171-180